Concarlo Holdings LLC, has today announced that US Patent 10,702,570 was issued by the United States Patent and Trademark Office on July 07, 2020, marking the latest step in Concarlo’s journey to commercialize revolutionary medicines for metastatic breast cancer.
Treating male urethral stricture with the patient’s own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan.
Huntington’s disease is a genetic disease that is debilitating and progressive leading to severe brain damage and eventual death. In patients with this autosomal dominant disease, there is presence of a protein called the Huntingtin protein that forms clumps within the brain leading to the symptoms of the disease.
New technology to improve dental implant bridges invented by Dr. Avinash Bidra, associate professor at the UConn School of Dental Medicine, recently received a patent from the United States Patent and Trademark Office.
Eccrine Systems, Inc., an advanced sweat sensor company, today announced that a key patent, US10136831, has been issued to Dr. Jason Heikenfeld, Co-Founder & CSO, and prominent University of Cincinnati researcher.
Co-Diagnostics, Inc., a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, announced today that it has been awarded a patent from the United States Patent and Trademark Office related to the Company's CoPrimer™ platform technology.
Fina Biosolutions announces that the United States Patent and Trademark Office has issued a patent for expression and purification of the conjugate vaccine protein CRM197 in E. coli.
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address liver diseases, inflammatory diseases and sexual dysfunction, today announced that the Australian and Chinese patent offices have granted the Company a patent for the utilization of A3 adenosine receptor ligands in the treatment of sexual dysfunction, in a patent (Australian, No. 2013301125ZL, Chinese No. 2013800472970) titled, "A3 adenosine receptor ligands for use in treatment of a sexual dysfunction."
The company GB Sciences Inc. has obtained the exclusive global worldwide intellectual property license for this innovative solution, which is based on nanotechnology.
Persavita Inc. is pleased to announce the successful issue of the United States patent for its flagship natural eye health product, Saffron 2020.
Quark Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office has granted a key patent covering the treatment of patients suffering from non-arteritic anterior ischemic optic neuropathy ("NAION") with the Company's ocular neuroprotectant QPI-1007.
Pluristem Therapeutics Inc. (PSTI), a leading developer of placenta-based cell therapy products, has announced that the Japan Patent Office has granted the Company two key patents addressing...
Medical devices company Coloplast has been granted patents for the colour of its new grey SenSura Mio stoma bag which makes it almost invisible under white clothing.